Takenori Takahata
Affiliations: | Hirosaki University, Aomori-shi, Aomori-ken, Japan |
Google:
"Takenori Takahata"Collaborators
Sign in to add collaborator| Robert A. Sclafani | collaborator | 2010-2011 | Hirosaki University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tanimoto A, Yagisawa M, Nakano S, et al. (2019) HGCSG1601: A retrospective cohort study of the efficacy and safety of nab-paclitaxel plus gemcitabine (nab-P+GEM) for unresectable locally advanced pancreatic cancer (LAPC) Annals of Oncology. 30 |
| Takahata T, Saito K, Chen Y, et al. (2019) Clinical feature of very elderly malignant lymphoma patients unfit for chemotherapy Annals of Oncology. 30 |
| Ueda A, Yuki S, Sasaki T, et al. (2014) Comparison of cetuximab (Cmab) with panitumumab (Pmab) monotherapy in salvage line against KRAS wild-type patients with metastatic colorectal cancer (mCRC): Analysis of HGCSG0901 and 1002. Journal of Clinical Oncology. 32: 663-663 |
| Yuki S, Komatsu Y, Fukushima H, et al. (2014) Phase II trial of S-1 plus split cisplatin (SSP) in patients with advanced gastric cancer (HGCSG0702): Final report. Journal of Clinical Oncology. 32: 113-113 |
| Nakamura M, Yuki S, Harada K, et al. (2014) O3-11-4Observational Cohort Study Of 1St Line Bevacizumab Combined With Chemotherapy In Metastatic Colorectal Cancer: Hgcsg0802 Annals of Oncology. 25 |
| Sclafani R, Agarwal R, Tyagi A, et al. (2014) Chemoprevention by Resveratrol in Head-and-Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 88: 512 |
| Iwanaga I, Yuki S, Fukushima H, et al. (2013) An open, multicenter, phase II clinical trial to evaluate efficacy and safety of S-1 split cisplatin in patients with advanced gastric cancer (AGC): HGCSG0702—Safety analysis. Journal of Clinical Oncology. 31: 121-121 |
| Tyagi A, Gu M, Takahata T, et al. (2011) Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5402-11 |
| Hanada N, Takahata T, Itoh J, et al. (2011) Abstract 102: Hypermethylation ofKeap1promoter and expression of the downstream genes in human colorectal cancer cell lines Cancer Research. 71: 102-102 |
| Takahata T, Ookawa K, Suto K, et al. (2008) Chemosensitivity Determinants of Irinotecan Hydrochloride in Hepatocellular Carcinoma Cell Lines Basic & Clinical Pharmacology & Toxicology. 102: 399-407 |